Gastrin: Growth enhancing effects on human gastric and colonic tumour cells

Abstract

Two colorectal (HT29, LoVo) and one gastric (MKN45) human tumour cell lines were examined for their in vitro trophic response to human gastrin-17. MKN45 and HT29 responded by increased75Se- selenomethionine uptake to exogenous gastrin (139 ±5.5% and 123 ±3% of control values respectively) whereas LoVo showed no significant response to this hormone. When these same cell lines were grown as xenografts in nude mice, similar responses were seen to exogenously administered human gastrin-17 (10 μg mouse−1day−1, subcutaneous injection). MKN45 xenografts showed a greater response to continuously administered gastrin (osmotic mini-pumps, (10 μg mouse−1day−1) when compared to the same dose given via a subcutaneous bolus injection. The hormone-treated xenografts had a two-fold increase in tumour crosssectional area and growth rate when compared to saline-treated controls. Dose-response studies revealed that 0.4 μg gastrin mouse−1day−1appeared to be the minimally effective dose. As gastric and colorectal tumour cells show a trophic response to gastrin, antagonists of the gastrin receptor may prevent this effect causing tumour stasis. The gastric tumour cell line, MKN45, is gastrin-responsive and would be an ideal model for screening potent receptor antagonists. © The Macmillan Press Ltd., 1989.